Cargando…

Signaling Network Map of Endothelial TEK Tyrosine Kinase

TEK tyrosine kinase is primarily expressed on endothelial cells and is most commonly referred to as TIE2. TIE2 is a receptor tyrosine kinase modulated by its ligands, angiopoietins, to regulate the development and remodeling of vascular system. It is also one of the critical pathways associated with...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, Aafaque Ahmad, Sandhya, Varot K., Singh, Priyata, Parthasarathy, Deepak, Kumar, Awinav, Advani, Jayshree, Gattu, Rudrappa, Ranjit, Dhanya V., Vaidyanathan, Rama, Mathur, Premendu Prakash, Prasad, T. S. Keshava, Mac Gabhann, F., Pandey, Akhilesh, Raju, Rajesh, Gowda, Harsha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4211299/
https://www.ncbi.nlm.nih.gov/pubmed/25371820
http://dx.doi.org/10.1155/2014/173026
Descripción
Sumario:TEK tyrosine kinase is primarily expressed on endothelial cells and is most commonly referred to as TIE2. TIE2 is a receptor tyrosine kinase modulated by its ligands, angiopoietins, to regulate the development and remodeling of vascular system. It is also one of the critical pathways associated with tumor angiogenesis and familial venous malformations. Apart from the vascular system, TIE2 signaling is also associated with postnatal hematopoiesis. Despite the involvement of TIE2-angiopoietin system in several diseases, the downstream molecular events of TIE2-angiopoietin signaling are not reported in any pathway repository. Therefore, carrying out a detailed review of published literature, we have documented molecular signaling events mediated by TIE2 in response to angiopoietins and developed a network map of TIE2 signaling. The pathway information is freely available to the scientific community through NetPath, a manually curated resource of signaling pathways. We hope that this pathway resource will provide an in-depth view of TIE2-angiopoietin signaling and will lead to identification of potential therapeutic targets for TIE2-angiopoietin associated disorders.